Literature DB >> 8807550

Pharmacokinetics of osthole in rat plasma using high-performance liquid chromatography.

T H Tsai1, T R Tsai, C C Chen, C F Chen.   

Abstract

A simple high-performance liquid chromatographic method was developed to study the pharmacokinetics of osthole in rat plasma. After addition of an internal standard (paeonol), plasma was deproteinized by acetonitrile for sample clean-up. The drugs were separated on a reversed-phase column and detected by UV absorption at 323 nm. Acetonitrile-water-diethylamine (50:50:0.1, v/v/v) (pH 3.0, adjusted with orthophosphoric acid) was used as the mobile phase. It was applied to the pharmacokinetic study of osthole in rats after a dose of 10 mg kg-1 by intravenous administration. A biphasic phenomenon with a rapid distribution followed by a slower elimination phase was observed from the plasma concentration-time curve.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8807550     DOI: 10.1016/0731-7085(95)01692-9

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  5 in total

1.  Nontargeted SWATH acquisition mode for metabolites identification of osthole in rats using ultra-high-performance liquid chromatography coupled to quadrupole time-of-flight mass spectrometry.

Authors:  Man Liao; Xinpeng Diao; Xiaoye Cheng; Yupeng Sun; Lantong Zhang
Journal:  RSC Adv       Date:  2018-04-19       Impact factor: 4.036

2.  Computational Screening of the Natural Product Osthole and Its Derivates for Anti-Inflammatory Activity.

Authors:  Angela Mosebarger; Rambabu N Reddi; Ramkumar Menon; Ananth Kumar Kammala
Journal:  Life (Basel)       Date:  2022-03-30

3.  Determination of osthol and its metabolites in a phase I reaction system and the Caco-2 cell model by HPLC-UV and LC-MS/MS.

Authors:  Zhenting Yuan; Haiyan Xu; Ke Wang; Zhonghua Zhao; Ming Hu
Journal:  J Pharm Biomed Anal       Date:  2008-12-09       Impact factor: 3.935

Review 4.  Osthole: A Review on Its Bioactivities, Pharmacological Properties, and Potential as Alternative Medicine.

Authors:  Zhong-Rong Zhang; Wing Nang Leung; Ho Yee Cheung; Chun Wai Chan
Journal:  Evid Based Complement Alternat Med       Date:  2015-07-13       Impact factor: 2.629

5.  Osthole ameliorates hepatic fibrosis and inhibits hepatic stellate cell activation.

Authors:  Ya-Wei Liu; Yung-Tsung Chiu; Shu-Ling Fu; Yi-Tsau Huang
Journal:  J Biomed Sci       Date:  2015-08-01       Impact factor: 8.410

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.